GTMS Relative Valuation - Greenbrook TMS Inc

Watchlist Manager

Watchlist

Price: 0.97 CAD -15.65%

Market Cap: CA$28.6m

	Greenbrook TMS Inc TSX:GTMS	CA
	Ono Pharmaceutical Co Ltd TSE:4528	JP
S	Sescom SA WSE:SES	PL
H	Hanil Cement Co Ltd KRX:300720	KR
A	Advanced Optoelectronic Technology Inc TWSE:3437	TW
	Reconditioned Systems Inc OTC:AMXX	US
K	Kyverna Therapeutics Inc NASDAQ:KYTX	US
T	TYM Corp KRX:002900	KR
K	Kerur Holdings Ltd TASE:KRUR	IL
Y	Yonyu Plastics Co Ltd TWSE:1323	TW
	Musashi Seimitsu Industry Co Ltd TSE:7220	JP
B	Business Engineering Corp TSE:4828	JP
	Samick Musical Instruments Co Ltd KRX:002450	KR
	Kansai Nerolac Paints Ltd NSE:KANSAINER	IN
A	Argenta Silver Corp OTC:AGAGF	CA
C	CPM Group Ltd HKEX:1932	HK
V	Vrain Solution Inc TSE:135A	JP
	Universal Inc TWSE:1325	TW
G	Gopeng Bhd KLSE:GOPENG	MY
	Wealthy Way Group Ltd HKEX:3848	HK
	Basler AG LSE:0DUI	DE
Z	Zhejiang Biyi Electric Appliance Co Ltd SSE:603215	CN
	Shri Bajrang Alliance Ltd BSE:526981	IN
C	Caladrius Biosciences Inc LSE:0HS8	US

Multiples-Based Value

There is not enough data to reliably calculate the multiples-based value of GTMS.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

GTMS Multiples-Based Value

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CA		Greenbrook TMS Inc TSX:GTMS	28.6m CAD	0.3	-0.3	-5.5	-3.8
US		CVS Health Corp NYSE:CVS	98.7B USD	0.2	54.2	13.9	13.9
US	C	Cigna Group XMUN:CGN	68.1B EUR	0.3	13.1	7.7	9.8
US		Cigna Corp NYSE:CI	71.8B USD	0.3	11.9	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.3B EUR	1.1	19.6	9.8	14.6
DE		Fresenius Medical Care AG XMUN:FME	23.7B EUR	1.2	23.7	9.1	16.8
US		Laboratory Corporation of America Holdings NYSE:LH	22.1B USD	1.6	25.2	12.1	17.5
US		Quest Diagnostics Inc NYSE:DGX	21.4B USD	1.9	21.6	11.8	15.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.1B EUR	0.6	11	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	11.3B USD	11.5	-27.1	-29.7	-27
US		DaVita Inc NYSE:DVA	10.2B USD	0.7	13.3	7	9.5

				Revenue Growth	P/S to Growth
CA		Greenbrook TMS Inc TSX:GTMS	Average P/S: 1.8 0.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	2%	0.6
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	1.9	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	2%	0.3
US		Guardant Health Inc NASDAQ:GH	11.5	29%	0.4
US		DaVita Inc NYSE:DVA	0.7	4%	0.2

				Earnings Growth	PEG
CA		Greenbrook TMS Inc TSX:GTMS	Average P/E: 21.5 Negative Multiple: -0.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	54.2	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.9	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.6	25%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.7	15%	1.6
US		Laboratory Corporation of America Holdings NYSE:LH	25.2	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.6	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11	15%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.1	N/A	N/A
US		DaVita Inc NYSE:DVA	13.3	19%	0.7

				EBITDA Growth	EV/EBITDA to Growth
CA		Greenbrook TMS Inc TSX:GTMS	Average EV/EBITDA: 9.6 Negative Multiple: -5.5	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.9	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	5%	1.5
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.8	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.1	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.1	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.7	N/A	N/A
US		DaVita Inc NYSE:DVA	7	4%	1.8

				EBIT Growth	EV/EBIT to Growth
CA		Greenbrook TMS Inc TSX:GTMS	Average EV/EBIT: 13.5 Negative Multiple: -3.8	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.9	22%	0.6
US	C	Cigna Group XMUN:CGN	9.8	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.6	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.8	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.5	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.8	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27	N/A	N/A
US		DaVita Inc NYSE:DVA	9.5	5%	1.9

Greenbrook TMS Inc
TSX:GTMS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GTMS Competitors Multiples
Greenbrook TMS Inc Competitors

See Also

Company

Help

Tools

Stocks

Greenbrook TMS Inc TSX:GTMS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GTMS Competitors Multiples Greenbrook TMS Inc Competitors

See Also

Company

Help

Tools

Stocks

Greenbrook TMS Inc
TSX:GTMS

GTMS Competitors Multiples
Greenbrook TMS Inc Competitors